The Moderna vaccine stored in the super freezer of the pharmacy at the Emile Muller hospital, in Mulhouse (Haut-Rhin). (Credit: Sébastien Bozon / AFP)
EFPIA, Vaccines Europe, IFPMA … The main associations of the European and American pharmaceutical industry call on governments not to play sorcerer’s apprenticeship with anti-Covid-19 vaccines, while several countries are tempted to increase the duration between the two doses to be injected or change the dose of vaccines, to deal with the lack of stocks.
Number of people vaccinated in France
Since December 26, 2020 (to January 13, 2021): 247,167 people
Breakdown by region
Number of people vaccinated
Share of people vaccinated per 100,000
Pays de la Loire
(Source: Directorate General of Health, January 13, 2021)
How France is positioned on a global scale
The stages of the vaccination schedule in France
Can currently be vaccinated:
Elderly people in EHPAD or in long-term care unit;
all caregivers over 50 or with co-morbidities;
firefighters over 50 years of age or with co-morbidities;
home helpers over 50 or with co-morbidities;
vulnerable disabled people cared for in nursing homes and specialized homes.
From Thursday January 14: registrations for those over 75, for a vaccination from January 18. Online at: Doctolib, Maiia and Keldoc.
Vaccines authorized in France
Moderna since January 8
Pfizer-Biotech since December 24
French factories already mobilized
If the Pfizer-BioNTech vaccine is currently produced in Belgium, in Pfizer’s Puurs plant, it will also be able to count from April on a French manufacture. The French pharmaceutical subcontractor Delpharm had indeed obtained in November 2020 a contract with BioNTech for the filling of several tens of millions of doses, on its site of Saint-Rémy-Sur-Avre (Eure-et-Loir).
Moderna has entrusted the Swedish group Recipharm, one of the main pharmaceutical subcontractors in Europe, with the formulation and filling-finishing operations of the first vaccines. They will take place in France “during the first half of 2021”, at the Recipharm de Monts site (Indre-et-Loire), a former AstraZeneca factory.
Another SME located in France will be involved in the manufacture of Moderna doses. The Chenôve site (Côte-d’Or), owned by the Swiss subcontractor CordenPharma, must supply lipid excipients, a molecule used in the composition of Moderna’s vaccine.
The different vaccine technologies
Inactivated, recombinant protein, messenger RNA or GMO … L’Usine Nouvelle disentangles here the true from the false on the four main technologies used to develop these anti-Covid-19 vaccines.
The classic killed or inactivated vaccine
Used by Chinese laboratories Sinopharm and Sinovac
Used by the French Sanofi, allied to its English competitor GSK
Used by Pfizer and BioNTech, but also by Moderna
The DNA vaccine is being tested by the French organization Institut Pasteur. Recombinant live vaccines are used by the American Janssen (a subsidiary of J&J) and the Anglo-Swedish AstraZeneca.
*The article has been translated based on the content of UsineNouvelle – Actualités A la une by www.usinenouvelle.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!